Effects of antipsychotic drugs on action potential production in skeletal muscle. II. Haloperidol: nonspecific and opiate drug receptor mediated effects.
The effects of haloperidol, an antipsychotic butyrophenone, on excitability and action potential production in frog's sartorius muscle fibers were studied. This drug produced a local-anestheticlike effect which developed slowly over 1 to 5 h with lower concentrations (2.7 to 5.3 X 10(-6 M) but was completely reversed by exposing the muscles to a drug-free solution. In studies with intracellular microelectrodes, evidence was obtained showing that haloperidol decreased excitability and depressed action potential production by inhibiting the specific increase in sodium conductance (gNa) which normally follows an adequate stimulus. Evidence also was obtained showing an inhibition of the secondary increase in potassium conductance (gK). Haloperidol is structurally related to meperidine and it was found that the inhibition of gNa produced by haloperidol is partially antagonized by low concentrations of naloxone (2.8 X 10(-8) and 2.8 X 10(-7) M); as was previously shown for meperidine. Thus haloperidol, like meperidine, suppresses action potential production by two mechanisms of action: one, a nonspecific local-anaestheticlike effect; and the other, a specific inhibition of gNa mediated by means of an opiate drug receptor associated with the muscle fiber membrane. Naloxone did not antagonize the effects of chlorpromazine on gNa.
D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D001001:Anura; D002746:Chlorpromazine / Q000494:pharmacology; D004558:Electric Stimulation; D006220:Haloperidol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D066298:In Vitro Techniques; D009132:Muscles / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D009270:Naloxone / Q000494:pharmacology; D011894:Rana pipiens; D011957:Receptors, Opioid / Q000187:drug effects / Q000502:physiology*; D012964:Sodium / Q000494:pharmacology; D013997:Time Factors
D011957:Receptors, Opioid; D009270:Naloxone; D012964:Sodium; D006220:Haloperidol; D002746:Chlorpromazine